BCCL
Clinical Stage: Phase III
Russia’s potential COVID-19 vaccine, Sputnik V, is under Phase III trials. Gamaleya Research Institute — a part of Russia’s Health Ministry — is testing the virus on over 40,000 people.
Several scientists across the world have been criticizing Russia over safety concerns. According to Russian health minister Mikhail Murashko, one in seven volunteers had side effects after they had a shot of Sputnik V.
“Approximately 14% have small complaints of weakness, muscle pain for 24 hours and an occasional increase in body temperature,” reported Russian Agency TASS quoting Murashko.
On September 8, the Russian government sought India’s help in manufacturing the Sputnik V vaccine and also to conduct Phase III trials in India.